Please login to the form below

Not currently logged in
Email:
Password:

government strategy

This page shows the latest government strategy news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more

Daily Brief: UK must follow through on Life Sciences Strategy, haemophilia gene therapy latest and more

Lilly says it also believes the government can “reassure global investors in the short-term”through “full implementation of the Life Sciences Industrial Strategy, ”the blueprint it unveiled in December.. ... By implementing the Life Sciences

Latest news

More from news
Approximately 11 fully matching, plus 54 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare

    ecosystem. MSD’s expansion over the coming years will help the company hold the government to its promises included in the Life Sciences Sector Deal. ... Louise was also involved in the launch of the government’s Industrial Strategy last year, which

  • Lighting the way Lighting the way

    That new industrial strategy (see p7) hands a prominent role to life sciences, naming it as the first of 10 strategic pillars that will be leant upon to support the ... She noted that engaging with the government on the new Life Sciences Strategy (see p7)

  • Bringing about digital health change Bringing about digital health change

    Regulators are not a problem, Valencia states, and providers - such as the NHS - have shown openness to change, which is enshrined in the UK government's Five Year Forward strategy. “ ... Digital inspiration for pharma on mobile, social media, strategy,

  • Russian innovation at the crossroads Russian innovation at the crossroads

    The government came up with a strategy to develop high technology sectors such as pharmaceuticals, electronics, nanotechnology and others. ... During the first three years of Strategy's implementation (2011-2013), the key objective for the government was

  • Creating a 21st century life sciences ecosystem Creating a 21st century life sciences ecosystem

    Freeman also helped put together the coalition government's 'Strategy for UK Life Sciences' in 2011, a major piece of policy for the industry. ... Market access. The biggest issue for pharma, and therefore for the government, is market access.

More from intelligence
Approximately 3 fully matching, plus 6 partially matching documents found.

Latest appointments

  • IFPMA appoints Fumie Griego as assistant director general IFPMA appoints Fumie Griego as assistant director general

    She joins from Merck KGaA, where she held senior roles such as head of global oncology policy and strategy, global government affairs policy and has also served as vice president for

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    She brings further pharmaceutical management experience from California-based Salick Health Care, where she was vice president of strategy, and management consultancy expertise from KPMG. ... Lisa will play a leading role as we negotiate the future of

  • Former Sanofi exec Joseph Devaney joins Astellas Former Sanofi exec Joseph Devaney joins Astellas

    Jeffrey Winton, senior vice president of corporate affairs at Astellas, said: “ Joe's experience and leadership will elevate our highly collaborative team of senior government strategy, policy, legislative and regulatory professionals ... His role in

  • Astellas adds to US comms team Astellas adds to US comms team

    Astellas continued to strengthen its communication and public affairs efforts in the US with the appointment of Marty Golden as VP, government affairs. ... In this role, Golden will lead federal government affairs, state government affairs, therapeutic

  • Sir Tom Blundell to remain as chair of UK’s biotech research council Sir Tom Blundell to remain as chair of UK’s biotech research council

    Reappointed to government role to support research. Sir Tom Blundell has been reappointed as chair of the UK's Biotechnology and Biological Sciences Research Council (BBSRC), a government-funded organisation to

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Shining a light on the true cost of patient care

    When Sir John Bell recently published his recommendations for the Life Sciences strand of the Government’ s Industrial Strategy, he said that the NHS’ s structure gives it data sharing opportunities ... However, before this can happen, the Government

  • Getting to grips with Russia’s healthcare market

    Increasing GDP, rising consumer incomes and government strategy to transform the nation’ s healthcare are the key growth drivers. ... national Vital and Essential Drug list, making inclusion on this more importantand reducing the importance of a

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics